Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Taking vitamin D and calcium supplements reduces the risk of hip fractures by about one sixth, but taking vitamin D alone does not, according to a new study from the Nuffield Department of Population Health (NDPH) at the University of Oxford.

None © Shutterstock

The research was led by Research Fellow Dr Pang Yao and Robert Clarke, Professor of Epidemiology and Public Health Medicine, at NDPH. The researchers combined findings from 11 observational studies of vitamin D blood levels and the associated risk of fracture with more than 39,000 participants, 6 trials of combined vitamin D and calcium treatment with more than 49,000 participants, and 11 trials of vitamin D supplements alone with 34,000 participants. The research has been published in JAMA Network Open.

The observational studies showed that low blood levels of vitamin D are associated with higher risks of fracture, but the trial results have been inconclusive. The trials of vitamin D plus calcium showed a small reduction in the risk of fractures. In people over the age of 80 years, and those living in institutions however, the effects were greater, with the risk of hip fracture lowered by almost one-third. While the trials of vitamin D alone did not show a reduction in the risk of fracture, these trials included some large studies of very high annual doses of vitamin D which increased the risk of fracture, and few of the trials tested doses of vitamin D high enough to raise the blood levels of vitamin D sufficiently to reduce the fracture risk.

Read more (University of Oxford)

Similar stories

Researchers develop machine learning algorithm to diagnose deep vein thrombosis

A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don’t have it.

COVID-19 recovery project nominated for HSJ award

The project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine is in the running for a prestigious honour at the Health Service Journal Awards 2021.

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.

Blood bank storage can reduce ability of transfusions to treat anaemia

New research from Department of Physiology, Anatomy & Genetics (DPAG), in collaboration with NHS Blood and Transplant, has demonstrated that the process of storing blood in blood banks can negatively impact the function of red blood cells and consequently may reduce the effectiveness of blood transfusions, a treatment commonly used to combat anaemia.